News

NEOVACS announced its financial results for the year to 31 December 2013 as approved by the Board of Directors on March 26th 2014.

A public-private research initiative between GSK, the European Bioinformatics Institute and the Wellcome Trust Sanger Institute aims to harness the power of "big data" and genome sequencing to improve the success rate for discovering new medicines.

Also accredited: first organization in the Middle East, second in Taiwan, and St. Jude Children's Research Hospital